Lataa...
Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma
Doxorubicin (DOX) is commonly used to treat human malignancies, and its efficacy can be maximized by limiting the cardiac toxicity when combined with nanoparticles. Here, we reported a unique type of reversibly disulfide cross-linked micellar formulation of DOX (DOX-DCMs) for the targeted therapy of...
Tallennettuna:
| Julkaisussa: | Nanoscale |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980239/ https://ncbi.nlm.nih.gov/pubmed/29682647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8nr00680f |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|